We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+21.83%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$8.7M
Cap. Flow
-$1.24M
Cap. Flow %
-1.08%
Top 10 Hldgs %
36.88%
Holding
101
New
4
Increased
12
Reduced
48
Closed
4

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$912K
2
INTC icon
Intel
INTC
+$677K
3
RNG icon
RingCentral
RNG
+$354K
4
TELA icon
TELA Bio
TELA
+$245K
5
INUV icon
Inuvo
INUV
+$202K

Top Sells

Rank Stock Value
1
RMTI icon
Rockwell Medical
RMTI
+$747K
2
MMM icon
3M
MMM
+$529K
3
BIOL
Biolase, Inc.
BIOL
+$430K
4
AUGX
Augmedix, Inc. Common Stock
AUGX
+$332K
5
AMD icon
Advanced Micro Devices
AMD
+$229K

Sector Composition

Rank Sector Weight
1 Healthcare 55.14%
2 Technology 24.2%
3 Industrials 9.3%
4 Communication Services 6.4%
5 Consumer Staples 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPAY
26
DELISTED
FlexShopper
FPAY
$1.64M 1.43%
1,282,543
-14,417
-1% -$14K
GIS icon
27
General Mills
GIS
$19.1B
$1.52M 1.33%
19,825
– –
ATRC icon
28
AtriCure
ATRC
$1.92B
$1.5M 1.31%
30,350
-3,000
-9% -$138K
ABBV icon
29
AbbVie
ABBV
$443B
$1.48M 1.29%
11,008
-500
-4% -$73.3K
OPRX icon
30
OptimizeRx
OPRX
$114M
$1.46M 1.27%
101,863
– –
INUV icon
31
Inuvo
INUV
$15.1M
$1.41M 1.22%
633,071
+69,963
+12% +$202K
MDXH icon
32
MDxHealth
MDXH
$21.5M
$1.38M 1.2%
403,225
-5,500
-1% -$20.1K
MRK icon
33
Merck
MRK
$322B
$1.36M 1.19%
11,825
– –
SKYT icon
34
SkyWater Technology
SKYT
$1.29M 1.12%
136,500
-3,500
-3% -$33.6K
VCEL icon
35
Vericel Corp
VCEL
$2.35B
$1.24M 1.08%
32,867
-1,000
-3% -$32.9K
PDCO
36
DELISTED
Patterson Companies, Inc.
PDCO
$1.11M 0.97%
33,470
-500
-1% -$13.8K
APYX icon
37
Apyx Medical
APYX
$173M
$1.09M 0.95%
216,000
-8,800
-4% -$44.6K
GILD icon
38
Gilead Sciences
GILD
$162B
$1.05M 0.91%
13,617
– –
BMY icon
39
Bristol-Myers Squibb
BMY
$133B
$1M 0.87%
15,641
– –
TGT icon
40
Target
TGT
$65.6B
$986K 0.86%
7,475
– –
BAX icon
41
Baxter International
BAX
$13.5B
$954K 0.83%
+20,934
New +$912K
AAPL icon
42
Apple
AAPL
$4.54T
$902K 0.79%
4,650
– –
EGHT icon
43
8x8 Inc
EGHT
$269M
$895K 0.78%
211,500
– –
ELUT icon
44
Elutia
ELUT
$37.9M
$824K 0.72%
348,948
+73,619
+27% +$155K
FBIO icon
45
Fortress Biotech
FBIO
$104M
$780K 0.68%
94,601
– –
XGN icon
46
Exagen
XGN
$109M
$765K 0.67%
263,905
+4,000
+2% +$11.4K
CIEN icon
47
Ciena
CIEN
$53.4B
$733K 0.64%
17,250
-750
-4% -$34.2K
INTC icon
48
Intel
INTC
$455B
$721K 0.63%
+21,550
New +$677K
BLFS icon
49
BioLife Solutions
BLFS
$1.53B
$685K 0.6%
31,000
-1,000
-3% -$21.1K
ACHV icon
50
Achieve Life Sciences
ACHV
$659M
$655K 0.57%
126,212
-11,000
-8% -$77.1K
1
2
3 4 5

Similar funds

SVP
Strategic Value Partners Greenwich, Connecticut $133M AUM
PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return

Perkins Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Perkins Capital Management held 101 positions worth $115M, up 8.2% from $106M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Perkins Capital Management's Q2 2023 filing shows 4 new, 12 increased, 48 reduced and 4 closed positions. Its largest new stake was Baxter International: 20,934 shares worth $954K. The largest sale was Rockwell Medical, an estimated $747K.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 57% a quarter earlier, followed by Technology and Industrials.

  • Perkins Capital Management's largest Q2 2023 buy was Baxter International: 20,934 shares worth $954K.
  • Perkins Capital Management added most to TELA Bio in Q2 2023, an estimated $245K increase.
  • Perkins Capital Management's biggest Q2 2023 reduction was Rockwell Medical, cutting an estimated $747K.
  • Perkins Capital Management fully exited 3M in Q2 2023, selling an estimated $529K.
  • Perkins Capital Management's ten largest holdings make up 37% of its $115M portfolio in Q2 2023.
  • Perkins Capital Management opened 4 new positions and closed 4 in Q2 2023.
  • Perkins Capital Management's portfolio value rose 8.2% quarter-over-quarter to $115M.

Based on Perkins Capital Management's 13F filing for Q2 2023, filed 21 Jul 2023.